Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRV vaccine safety, reactogenicity, and immunogenicity in preterm infants
2006-003762-33Phase 3Completed
- Sponsor
- GSK
- Start
- Oct 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in rotaviral diarrhea comparing RIX4414 vaccine with Placebo (2 arms). Primary endpoint: Occurrence of serious adverse events throughout the study period. Started Oct 2006; status: completed.
02
Drugs
human rotavirus RIX4414 strain vaccine
03
Conditions
rotaviral diarrhea
Beyond the preview
Go deeper on 2006-003762-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003762-33.